Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AbbVie
Marketing
Docs discuss ongoing Humira use, name preferred biosimilars
Spherix polled doctors on AbbVie’s retention of Humira sales, shedding light on the forces shaping the market and their preferred biosimilar options.
Nick Paul Taylor
Sep 24, 2024 7:20am
BMJ says newer migraine drugs less effective than older triptans
Sep 19, 2024 11:32am
Akeso-Summit, BIOSECURE, Candid and more—Fierce Pharma Asia
Sep 13, 2024 8:53am
FDA slams AbbVie for misleading claims in Serena Williams ad
Sep 12, 2024 6:48am
AbbVie's Ubrelvy to be top migraine seller in 2033
Sep 10, 2024 7:15am
AbbVie maintains grip on TV drug ad spending list
Sep 5, 2024 10:22am
.png?VersionId=24U1NxNbQTfhLnvjFrEI31KJrQnszBpf)